Found: 247
Select item for more details and to access through your institution.
The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Management of breast cancer diagnosed during pregnancy.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The Extermann Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 11, p. 1362
- By:
- Publication type:
- Article
Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 7, p. 721, doi. 10.1016/j.clbc.2023.06.014
- By:
- Publication type:
- Article
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Practice Patterns in the Delivery of Radiation Therapy After Mastectomy Among the University of California Athena Breast Health Network.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 1, p. 43, doi. 10.1016/j.clbc.2014.07.005
- By:
- Publication type:
- Article
Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 6, p. 421, doi. 10.1016/j.clbc.2013.08.011
- By:
- Publication type:
- Article
Proceedings of the First Global Workshop on Breast Cancer: Pathways to the Evaluation and Clinical Development of Novel Agents for Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 421, doi. 10.3816/CBC.2010.n.056
- By:
- Publication type:
- Article
Challenging Clinical Scenarios: Treatment of Patients With Triple-Negative or Basal-Like Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, p. S20, doi. 10.3816/CBC.2010.s.009
- By:
- Publication type:
- Article
Effect of Trastuzumab on Health-Related Quality of Life in Patients With HER2-Positive Metastatic Breast Cancer: Data From Three Clinical Trials.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 288, doi. 10.3816/CBC.2010.n.037
- By:
- Publication type:
- Article
Risk-Based Screening for Cancer in Patients With Dermatomyositis: Toward a More Individualized Approach.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.886954
- By:
- Publication type:
- Article
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31238-y
- By:
- Publication type:
- Article
Targeting Tumor Angiogenesis in Combination with Endocrine Therapy in Patients with Hormone-Receptor Positive Metastatic Breast Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2011, v. 3, n. 4, p. 24
- By:
- Publication type:
- Article
MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2001, v. 8, n. 6, p. 549, doi. 10.1007/s10434-001-0549-8
- By:
- Publication type:
- Article
Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 3, p. 625, doi. 10.1007/s10549-024-07339-1
- By:
- Publication type:
- Article
Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 3, p. 509, doi. 10.1007/s10549-023-07206-5
- By:
- Publication type:
- Article
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 249, doi. 10.1007/s10549-023-07147-z
- By:
- Publication type:
- Article
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 197, doi. 10.1007/s10549-023-07073-0
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 1, p. 137, doi. 10.1007/s10549-022-06771-5
- By:
- Publication type:
- Article
Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 3, p. 549, doi. 10.1007/s10549-022-06755-5
- By:
- Publication type:
- Article
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 2, p. 127, doi. 10.1007/s10549-022-06602-7
- By:
- Publication type:
- Article
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 3, p. 569, doi. 10.1007/s10549-022-06660-x
- By:
- Publication type:
- Article
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 103, doi. 10.1007/s10549-021-06267-8
- By:
- Publication type:
- Article
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 369, doi. 10.1007/s10549-021-06197-5
- By:
- Publication type:
- Article
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 179, doi. 10.1007/s10549-021-06103-z
- By:
- Publication type:
- Article
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 2, p. 387, doi. 10.1007/s10549-021-06234-3
- By:
- Publication type:
- Article
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 1, p. 155, doi. 10.1007/s10549-021-06109-7
- By:
- Publication type:
- Article
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 23, doi. 10.1007/s10549-020-05782-4
- By:
- Publication type:
- Article
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 161, doi. 10.1007/s10549-020-05838-5
- By:
- Publication type:
- Article
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 3, p. 623, doi. 10.1007/s10549-020-05603-8
- By:
- Publication type:
- Article
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 23, doi. 10.1007/s10549-020-05606-5
- By:
- Publication type:
- Article
Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 2, p. 401, doi. 10.1007/s10549-019-05309-6
- By:
- Publication type:
- Article
Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 303, doi. 10.1007/s10549-019-05238-4
- By:
- Publication type:
- Article
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 5, doi. 10.1007/s10549-018-05102-x
- By:
- Publication type:
- Article
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 3, p. 547, doi. 10.1007/s10549-018-4770-6
- By:
- Publication type:
- Article
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 1, p. 1, doi. 10.1007/s10549-018-4662-9
- By:
- Publication type:
- Article
NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1237751
- By:
- Publication type:
- Article
Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231216095
- By:
- Publication type:
- Article